Most community-based oncologists skip biomarker testingSeptember 21, 2021Lung CancerOncologyGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMelanoma
Although inconclusive, CV safety study of cancer therapy attracts attentionAugust 30, 2021OncologyGenitourinary Cancer
Ponatinib/blinatumomab start strong against Ph+ALLJune 25, 2021Leukemia, Myelodysplasia, Transplantation
Reduced-intensity transplant benefits older patients with AMLJune 22, 2021AMLLeukemia, Myelodysplasia, Transplantation
Experimental antibody-drug conjugate shown active against r/r DLBCLJune 15, 2021Lymphoma & Plasma Cell Disorders
Promising HER2+/HR– breast cancer survival with de-escalated therapyJune 15, 2021Breast CancerOncology
